Peter J Graham - Net Worth and Insider Trading
Peter J Graham Net Worth
The estimated net worth of Peter J Graham is at least $4 Million dollars as of 2024-04-26. Peter J Graham is the EVP General Counsel, Secretary of Antares Pharma Inc and owns about 540,417 shares of Antares Pharma Inc (ATRS) stock worth over $3 Million. Peter J Graham is also the Director of AngioDynamics Inc and owns about 92,466 shares of AngioDynamics Inc (ANGO) stock worth over $534,453. Details can be seen in Peter J Graham's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Peter J Graham has not made any transactions after 2021-02-18 and currently still holds the listed stock(s).
Transaction Summary of Peter J Graham
Peter J Graham Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Peter J Graham owns 3 companies in total, including Antares Pharma Inc (ATRS) , Delcath Systems Inc (DCTH) , and AngioDynamics Inc (ANGO) .
Click here to see the complete history of Peter J Graham’s form 4 insider trades.
Insider Ownership Summary of Peter J Graham
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
ATRS | Antares Pharma Inc | 2022-05-24 | See Remarks |
DCTH | Delcath Systems Inc | 2010-04-20 | EVP; General Counsel |
ANGO | AngioDynamics Inc | 2006-01-16 | director |
Peter J Graham Latest Holdings Summary
Peter J Graham currently owns a total of 2 stocks. Among these stocks, Peter J Graham owns 540,417 shares of Antares Pharma Inc (ATRS) as of February 18, 2021, with a value of $3 Million and a weighting of 84.97%. Peter J Graham also owns 92,466 shares of AngioDynamics Inc (ANGO) as of January 16, 2006, with a value of $534,453 and a weighting of 15.03%.
Latest Holdings of Peter J Graham
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
ATRS | Antares Pharma Inc | 2021-02-18 | 540,417 | 5.59 | 3,020,931 |
ANGO | AngioDynamics Inc | 2006-01-16 | 92,466 | 5.78 | 534,453 |
Holding Weightings of Peter J Graham
Peter J Graham Form 4 Trading Tracker
According to the SEC Form 4 filings, Peter J Graham has made a total of 1 transactions in Antares Pharma Inc (ATRS) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Antares Pharma Inc is the sale of 45,000 shares on February 18, 2021, which brought Peter J Graham around $221,850.
According to the SEC Form 4 filings, Peter J Graham has made a total of 0 transactions in AngioDynamics Inc (ANGO) over the past 5 years. The most-recent trade in AngioDynamics Inc is the sale of 0 shares on January 16, 2006, which brought Peter J Graham around $0.
Insider Trading History of Peter J Graham
- 1
Peter J Graham Trading Performance
GuruFocus tracks the stock performance after each of Peter J Graham's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Peter J Graham is 28.75%. GuruFocus also compares Peter J Graham's trading performance to market benchmark return within the same time period. The performance of stocks bought by Peter J Graham within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Peter J Graham's insider trading performs compared to the benchmark.
Performance of Peter J Graham
Average Return
231.25%
Outperforming Transactions
100%
1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
---|---|---|---|---|---|---|
Return(%) | 15 | 28.75 | 101.25 | 231.25 | 68.08 | 60.54 |
Relative Return to S&P 500(%) | 13.06 | 26.93 | 95.81 | 217 | 53.11 | 48.9 |
Peter J Graham Ownership Network
Ownership Network List of Peter J Graham
Ownership Network Relation of Peter J Graham
Peter J Graham Owned Company Details
What does Antares Pharma Inc do?
Who are the key executives at Antares Pharma Inc?
Peter J Graham is the See Remarks of Antares Pharma Inc. Other key executives at Antares Pharma Inc include See Remarks Peter C Richardson , Executive Vice President & CFO Fred M Powell , and director & President & CEO Robert F Apple .
Antares Pharma Inc (ATRS) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Antares Pharma Inc (ATRS) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Antares Pharma Inc (ATRS) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Antares Pharma Inc (ATRS)'s detailed insider trading history can be found in Insider Trading Tracker table.
Antares Pharma Inc Insider Transactions
Peter J Graham Mailing Address
Above is the net worth, insider trading, and ownership report for Peter J Graham. You might contact Peter J Graham via mailing address: 315 E. 72nd St., Apt 5e, New York Ny 10021.